We identified two drug targets in COAD as follows: the first one is FANCD2 (ferroptosis negative regulator, down), and it is involved in ferroptosis, a newly described cell death mechanism potentially used as cancer therapy [33]. Here, FANCD2 is linked to colon adenocarcinoma.